TRIB2 expression is positively associated with leukaemia patients that have FLT3 mutated t(15;17) genetics8, and with patients with elevated BCL2 expression46, and is negatively associated with leukaemia patients that have NPM1 and FLT3 mutations16. Here, NPM1 is linked to leukemia.